targeted therapy
Mutant RAS Proteins Team Up for Oncogenicity
Mutant RAS Proteins Team Up for Oncogenicity
Jim Daley | Mar 31, 2018
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.
Clinical Matchmaker
Clinical Matchmaker
Kate Yandell | May 31, 2015
Enrolling the right patient population could be key to a successful clinical trial.